El cáncer es una enfermedad muy común y muy difícil de tratar. Las estadísticas actuales sobre el cáncer muestran que una de cada tres personas que viven en países desarrollados será diagnosticada con cáncer, y que la mayoría de ellas no superarán la enfermedad. Muchos pacientes de cáncer son diagnosticados cuando sus células tumorales ya se...
-
December 14, 2020 (v1)PublicationUploaded on: December 4, 2022
-
October 7, 2016 (v1)Publication
Epidemiological studies have found a positive association between coffee consumption and a lower risk of cardiovascular disorders, some cancers, diabetes, Parkinson and Alzheimer disease. Coffee consumption, however, has also been linked to an increased risk of developing some types of cancer, including bladder cancer in adults and leukemia in...
Uploaded on: March 27, 2023 -
September 30, 2022 (v1)Publication
New therapies are needed to improve the low survival rates of patients with metastatic colon cancer. Evidence suggests that amino acid (AA) restriction can be used to target the altered metabolism of cancer cells. In this work, we evaluated the therapeutic potential of selective AA restriction in colon cancer. After observing anticancer...
Uploaded on: December 4, 2022 -
March 16, 2023 (v1)Publication
Sulfur-containing amino acids methionine (Met), cysteine (Cys) and taurine (Tau) are common dietary constituents with important cellular roles. Met restriction is already known to exert in vivo anticancer activity. However, since Met is a precursor of Cys and Cys produces Tau, the role of Cys and Tau in the anticancer activity of Met-restricted...
Uploaded on: March 25, 2023 -
March 16, 2023 (v1)Publication
Patients with metastatic triple negative breast cancer (TNBC) need new therapies to improve the low survival rates achieved with standard treatments. In this work, we show for the first time that the survival of mice with metastatic TNBC can be markedly increased by replacing their normal diet with artificial diets in which the levels of amino...
Uploaded on: March 25, 2023 -
January 19, 2023 (v1)Publication
Targeted therapies with antiangiogenic drugs (e.g., sunitinib) and immune checkpoint inhibitors (e.g., anti-PD-1 antibodies) are the standard of care for patients with metastatic renal cell carcinoma. Although these treatments improve patient survival, they are rarely curative. We previously hypothesized that advanced cancers might be treated...
Uploaded on: March 3, 2023 -
January 12, 2024 (v1)Publication
Since plants are an important source of anticancer drugs, we have carried out a random screening for selective anticancer activity of 57 extracts from 45 plants collected in Grazalema Natural Park, an area in the South of Spain of high plant diversity and endemism. Using lung cancer cells (A549) and lung non-malignant cells (MRC-5), we found...
Uploaded on: January 14, 2024 -
December 20, 2023 (v1)Publication
first_pagesettingsOrder Article Reprints Open AccessArticle Repurposing Study of 4-Acyl-1-phenylaminocarbonyl-2-substituted-piperazine Derivatives as Potential Anticancer Agents—In Vitro Evaluation against Breast Cancer Cells by Emilio Guillén-Mancina 1,†,María del Rosario García-Lozano 2,3,†ORCID,Estefanía Burgos-Morón 1ORCID,Sarah Mazzotta...
Uploaded on: December 25, 2023 -
December 9, 2021 (v1)Publication
Finding cytotoxic drugs with a high selectivity towards cancer cells is crucial to improve the low survival rates of patients diagnosed with metastatic cancers. Since plants are an important source of anticancer drugs, we have screened 65 extracts from 45 plants collected in several areas of Western Andalusia (Spain) for cytotoxic activity on...
Uploaded on: December 4, 2022